Role of phosphatidylinositol signaling pathway in the development of cross-resistance of tumor cells to hormonal cytostatics and hypoxia

被引:0
|
作者
Shatskaya, V. A. [1 ]
Pavlichenko, O. V. [1 ]
Krasil'nikov, M. A. [1 ]
机构
[1] Russian Acad Med Sci, NN Blokhin Res Canc Res Ctr, Moscow 109801, Russia
基金
俄罗斯基础研究基金会;
关键词
ovarian adenocarcinoma; dexamethasone; hypoxia; phosphatidylinositol; 3-kinase; proliferation;
D O I
10.1007/s10517-007-0061-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Long-term in vitro culturing of CaOv ovarian adenocarcinoma cells in the presence of a synthetic analogue of glucocorticoid hormone dexamethasone allowed us to obtain a subline of CaOv/D cells resistant to the antiproliferative effect of dexamethasone and characterized by high resistance to hypoxia. It was found that CaOv/D cells are characterized by constitutive increase in phosphatidylinositol 3-kinase expression and hypersecretion of vascular endothelial growth factor VEGF-A. Culturing of cells under hypoxic conditions was accompanied by a significant increase in phosphatidylinositol 3-kinase expression and VEGF-A synthesis. Experiments with cell transfection with phosphatidylinositol 3-kinase catalytic subunit proved its participation in the regulation of VEGF-A synthesis and maintenance of cell growth under condition of hypoxia. Our results indicate that coordinated activation of phosphatidylinositol 3-kinase and VEGF-A can be a factor determining the development of cross-resistance of tumor cells to hormonal cytostatics and hypoxia.
引用
收藏
页码:244 / 247
页数:4
相关论文
共 50 条
  • [21] Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanisms
    Patel, Ruchi P.
    Kuhn, Skyler
    Yin, Da
    Hotz, Jordan M.
    Maher, Frances A.
    Robey, Robert W.
    Gottesman, Michael M.
    Horibata, Sachi
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [22] Role of Phosphatidylinositol-3 Kinase in Regulation of Differential Sensitivity of Melanoma Cells to Antitumor Agents. A Model for Hormone Resistance Development in Tumor Cells
    M. A. Krasil'nikov
    E. V. Luzai
    A. M. Scherbakov
    V. A. Shatskaya
    A. A. Shtil
    E. S. Gershtein
    Biochemistry (Moscow), 2004, 69 : 322 - 330
  • [23] LACK OF CROSS-RESISTANCE TO A NEW CYTOTOXIC ARYLCHLOROETHYL UREA IN VARIOUS DRUG-RESISTANT TUMOR-CELLS
    GAUDREAULT, RC
    ALAOUIJAMALI, MA
    BATIST, G
    BECHARD, P
    LACROIX, J
    POYET, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 33 (06) : 489 - 492
  • [24] Role of phosphatidylinositol-3 kinase in regulation of differential sensitivity of melanoma cells to antitumor agents. A model for hormone resistance development in tumor cells
    Krasil'nikov, MA
    Luzai, EV
    Scherbakov, AM
    Shatskaya, VA
    Shtil, AA
    Gershtein, ES
    BIOCHEMISTRY-MOSCOW, 2004, 69 (03) : 322 - 330
  • [25] Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
    Chen, Kuen-Feng
    Chen, Hui-Ling
    Tai, Wei-Tien
    Feng, Wen-Chi
    Hsu, Chih-Hung
    Chen, Pei-Jer
    Cheng, Ann-Lii
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 337 (01): : 155 - 161
  • [26] The role of endothelin axis signaling pathway in astrocyte mediated chemoprotection of tumor cells.
    Kim, Seung Wook
    Kim, Sun Jin
    Choi, Hyun Jin
    Lee, Ho-Jeong
    He, Junqin
    Wu, Qiuyu
    Lawson, Erica J.
    Fidler, Isaiah J.
    CANCER RESEARCH, 2013, 73 (08)
  • [27] Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs
    Ozaki, Kei-ichi
    Kishikawa, Futaba
    Tanaka, Masashi
    Sakamoto, Toshiaki
    Tanimura, Susumu
    Kohno, Michiaki
    CANCER SCIENCE, 2008, 99 (02) : 376 - 384
  • [28] The role of the Wnt signaling pathway in cancer stem cells: prospects for drug development
    Kim, Yong-Mi
    Kahn, Michael
    RESEARCH AND REPORTS IN BIOCHEMISTRY, 2014, 4 : 1 - 12
  • [29] INCREASE OF ALKALINE-PHOSPHATASE IN MULTIDRUG-RESISTANT TUMOR-CELLS AND THEIR CROSS-RESISTANCE TO 6-THIOGUANINE
    EFFERTH, T
    VOLM, M
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1993, 43-2 (10): : 1118 - 1121
  • [30] DEMONSTRATION OF ANTINEOPLASTIC DRUG CROSS-RESISTANCE IN PRIMARY CULTURES OF HUMAN-TUMOR CELLS USING THE ADHESIVE TUMOR-CELL CULTURE SYSTEM
    HEAD, JF
    FOSTER, LB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 22 - 22